Cosmetic Dossier
Cosmetic Dossier
EMERGENCY OVERVIEW:
This is a personal care or cosmetic product that is safe for consumers and other users under
intended and reasonably foreseeable use. Additional information on toxicological endpoints is
available from the supplier upon request.
Eye:
Thorough rinsing for 15-20 minutes of the affected eye with water is recommended. If
discomfort or irritation persists, contact a physician.
Skin Problem:
Discontinue use of product. Apply cold compresses to affected areas to relieve any discomfort.
If discomfort persists, contact a physician.
Inhalation:
If respiratory irritation occurs, remove individual to fresh air.
Ingestion:
Accidental ingestion of product may necessitate medical attention. In case of accidental
ingestion dilute with fluids (water or milk) and treat symptomatically. Do not induce vomiting.
Note: After first aid treatment, the caller should be advised that 1) a hospital emergency room or
family physician should be consulted if anything unusual occurs or appears necessary in the
judgment of the caller, and 2) that the subsequent management of the accident should be dictated
by any persistent symptoms and under the direction of the physician.
The product ingredients are expected to be safe for the environment at concentrations predicted
under normal use and accidental spill scenarios. Packaging components are compatible with the
conventional solid waste management practices. Additional information is available from the
supplier on request.
SECTION 13 - DISPOSAL CONSIDERATIONS
US Federal
The product described in this Material Safety Data Sheet is regulated under the Federal Food,
Drug, and Cosmetics Act and is safe to use as per directions on container, box or accompanying
literature (where applicable).
Canada
All ingredients are CEPA approved for import to Canada. This product has been classified in
accordance with the hazard criteria of the Canadian Controlled Products Regulations (CPR) and
this MSDS contains all information required by the CPR.
US States
CA Prop 65:
This product is not subject to warning labeling under California Proposition 65.
Other
Perfumes contained within the products covered by this MSDS comply with appropriate IFRA
guidance.
SECTION 16 TEST OF EVALUATION OF THE IRRITATING
POWER OF A COSMETICS PRODUCT
The purpose of this test aims to demonstrate the cutaneous irritating power of a single
substance or of a finished cosmetic product. To such purpose this study is runned out on
25 voluntary subjects in good conditions of health, who dont suffer of cutaneous
illnesses and running symptoms of allergy. To each volunteer us requested a specific
document of authorization.
The substance to test is used pure or diluted in different concentrations in oil of Vaseline
if liposoluble or in water if water-soluble. Such value of dilution has to be always
mentioned with the obtained results.
The substance to test is applied on the skin through aluminium thin type chambers on a
part of skin located on the back. The chambers are fixed to the skin with adhesive
bandaid, paying attention that the skin must be integral and should not present scratches,
The period of application is fixed in 48 hours, the results (for the evaluation of the test)
are taken after 30 minutes, 24 hours and 48 hours.
The parameters taken in consideration to express a possible adverse answer are:
ERYTHEMA-EDEMA-SCALING-ITCH-BURNING. The degree of intensity of the
answer is expressed on the basis of: NEG, POS, +,++,
TEST RESULTS
3. HAZARDS IDENTIFICATION.
3.1 DANGEROUS IN HEALTH AND PHYSIC INTEGRITY:
No specific dangers may be found in the normal use:
DISCLAIMER: This MSDS is intended to provide a brief summary of our knowledge and
guidance regarding the use of this material. The information contained here has been compiled
from sources considered by Peer Pharm Ltd. to be dependable and is accurate to the best of the
Companys knowledge. It is not meant to be an all-inclusive document on worldwide hazard
communication regulations.
This information is offered in good faith. Each user of this material needs to evaluate the
conditions of use and design the appropriate protective mechanisms to prevent employee
exposures, property damage or release to the environment. Peer Pharm Ltd. assumed no
responsibility for injury to the recipient or third persons, or for any damage to any property
resulting from misuse of the product.
Mali Brikman
Manager of Quality Assurance,
Date: 7/03/2013
Peer Pharm Ltd.
CERTIFICAT OF FREE SALE
PEER PHARM LTD engaged in the manufacture of the following product:
NEXUS CREAM
Declares
That the cosmetic products above mentioned made in the respect of the CEE directive
and of the regulations concerning the production of cosmetics in Italy.
Rapprochement of the legislations of the relative member states to the cosmetic products.
Dir. 76/768/CEE
Rapprochement of the legislations of the relative member states to the cosmetic products.
Common inventory and nomenclature of the used ingredients in the cosmetic products.
Dir. 96/335/CEE
Dir. 1223/2009/CE
and to the following Italian legislation:
Norms for the realization of the directive CEE on the production and sale of cosmetics.
L. 713 of the 11-10-1986:
DL 300 of the 10-09-1991
DL 126 of the 24-04-1997
DL 50 of the 15-02-2003
Relative measures for cosmetics, containing materials of animal origin and updating of the lists
attached to the L. 713.
DM 05-05-1996
DM 22-01-1999
Such products dont introduce any risk connected to BSE and are even made in accord with the
practices of good workmanship (ISO 22716 GMP) adopted in firm.
WE certified also that the products above listed are healthy and sure and they are freely and
largely sold in Italy and in all over countries of the European Community.